Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
6d
The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
Health and Me on MSN7d
FDA Gives A Green Light To Blujepa For Treating Uncomplicated UTIsFor the longest the only treatment available for an uncomplicated UTI was nitrofurantoin. But now, FDA has approved Blujepa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback